JP2005504734A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005504734A5 JP2005504734A5 JP2003508926A JP2003508926A JP2005504734A5 JP 2005504734 A5 JP2005504734 A5 JP 2005504734A5 JP 2003508926 A JP2003508926 A JP 2003508926A JP 2003508926 A JP2003508926 A JP 2003508926A JP 2005504734 A5 JP2005504734 A5 JP 2005504734A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- diaza
- hydrogen atom
- alkyl
- methoxycarbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 24
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 14
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 11
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 claims 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 11
- 125000001424 substituent group Chemical group 0.000 claims 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 7
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 6
- 125000003974 3-carbamimidamidopropyl group Chemical group C(N)(=N)NCCC* 0.000 claims 6
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 claims 5
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 claims 4
- 208000035143 Bacterial infection Diseases 0.000 claims 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims 4
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- -1 4-{[(t-butoxy) carbonyl] amino} butyl Chemical group 0.000 claims 3
- 125000003277 amino group Chemical group 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 claims 2
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 2
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- ZTVJJAASXFPCHR-UHFFFAOYSA-N O=S(=O)N=S(=O)=O Chemical compound O=S(=O)N=S(=O)=O ZTVJJAASXFPCHR-UHFFFAOYSA-N 0.000 claims 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 2
- 125000001475 halogen functional group Chemical group 0.000 claims 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 claims 2
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 claims 2
- 150000002825 nitriles Chemical class 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- QUOGESRFPZDMMT-RXMQYKEDSA-N (2r)-2-amino-6-(diaminomethylideneamino)hexanoic acid Chemical group OC(=O)[C@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-RXMQYKEDSA-N 0.000 claims 1
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 claims 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 claims 1
- LCGTWRLJTMHIQZ-UHFFFAOYSA-N 5H-dibenzo[b,f]azepine Chemical compound C1=CC2=CC=CC=C2NC2=CC=CC=C21 LCGTWRLJTMHIQZ-UHFFFAOYSA-N 0.000 claims 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 1
- 125000002038 D-arginyl group Chemical group N[C@@H](C(=O)*)CCCNC(=N)N 0.000 claims 1
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine group Chemical group N[C@H](CCCCN)C(=O)O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 claims 1
- 241000192125 Firmicutes Species 0.000 claims 1
- 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 claims 1
- 241000191967 Staphylococcus aureus Species 0.000 claims 1
- 108010059993 Vancomycin Proteins 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 claims 1
- 235000008206 alpha-amino acids Nutrition 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 150000001576 beta-amino acids Chemical group 0.000 claims 1
- ZDZHCHYQNPQSGG-UHFFFAOYSA-N binaphthyl group Chemical group C1(=CC=CC2=CC=CC=C12)C1=CC=CC2=CC=CC=C12 ZDZHCHYQNPQSGG-UHFFFAOYSA-N 0.000 claims 1
- 235000010290 biphenyl Nutrition 0.000 claims 1
- 239000004305 biphenyl Substances 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 150000002016 disaccharides Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 150000002772 monosaccharides Chemical group 0.000 claims 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 claims 1
- 229960003165 vancomycin Drugs 0.000 claims 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR6044A AUPR604401A0 (en) | 2001-06-29 | 2001-06-29 | Peptoid compounds |
| PCT/AU2002/000850 WO2003002545A1 (en) | 2001-06-29 | 2002-06-28 | Peptoid compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008266473A Division JP2009108054A (ja) | 2001-06-29 | 2008-10-15 | ペプトイド化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005504734A JP2005504734A (ja) | 2005-02-17 |
| JP2005504734A5 true JP2005504734A5 (enExample) | 2005-12-22 |
| JP4446736B2 JP4446736B2 (ja) | 2010-04-07 |
Family
ID=3830009
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003508926A Expired - Fee Related JP4446736B2 (ja) | 2001-06-29 | 2002-06-28 | ペプトイド化合物 |
| JP2008266473A Pending JP2009108054A (ja) | 2001-06-29 | 2008-10-15 | ペプトイド化合物 |
| JP2011220320A Pending JP2012067103A (ja) | 2001-06-29 | 2011-10-04 | ペプトイド化合物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008266473A Pending JP2009108054A (ja) | 2001-06-29 | 2008-10-15 | ペプトイド化合物 |
| JP2011220320A Pending JP2012067103A (ja) | 2001-06-29 | 2011-10-04 | ペプトイド化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US7160854B2 (enExample) |
| EP (2) | EP1412336A4 (enExample) |
| JP (3) | JP4446736B2 (enExample) |
| AU (4) | AUPR604401A0 (enExample) |
| CA (1) | CA2451768C (enExample) |
| ES (1) | ES2534458T3 (enExample) |
| WO (1) | WO2003002545A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR604401A0 (en) * | 2001-06-29 | 2001-07-26 | University Of Wollongong, The | Peptoid compounds |
| PL374971A1 (en) | 2002-08-09 | 2005-11-14 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds and methods to modulate coagulation |
| US7208601B2 (en) | 2003-08-08 | 2007-04-24 | Mjalli Adnan M M | Aryl and heteroaryl compounds, compositions, and methods of use |
| WO2005014532A1 (en) | 2003-08-08 | 2005-02-17 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions and methods of use |
| CN102584939B (zh) * | 2005-01-13 | 2014-08-06 | 卧龙岗大学 | 肽化合物 |
| AU2005325054B2 (en) * | 2005-01-13 | 2012-09-20 | University Of Wollongong | Peptidic compounds |
| JP5109116B2 (ja) * | 2006-07-21 | 2012-12-26 | 国立大学法人 岡山大学 | 光学活性な大環状化合物、その製造法およびその利用 |
| WO2013026015A1 (en) | 2011-08-18 | 2013-02-21 | Dana-Farber Cancer Institute, Inc. | Muc1 ligand traps for use in treating cancers |
| JP2016027001A (ja) * | 2012-10-31 | 2016-02-18 | 塩野義製薬株式会社 | 抗菌活性を有するカルノサジンラクタム誘導体 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6881719B2 (en) * | 2000-01-18 | 2005-04-19 | Mcgill University | β-turn peptidomimetic cyclic compounds |
| AUPR604401A0 (en) * | 2001-06-29 | 2001-07-26 | University Of Wollongong, The | Peptoid compounds |
-
2001
- 2001-06-29 AU AUPR6044A patent/AUPR604401A0/en not_active Abandoned
-
2002
- 2002-06-28 JP JP2003508926A patent/JP4446736B2/ja not_active Expired - Fee Related
- 2002-06-28 ES ES11158209.4T patent/ES2534458T3/es not_active Expired - Lifetime
- 2002-06-28 US US10/481,663 patent/US7160854B2/en not_active Expired - Fee Related
- 2002-06-28 AU AU2002312656A patent/AU2002312656B8/en not_active Ceased
- 2002-06-28 WO PCT/AU2002/000850 patent/WO2003002545A1/en not_active Ceased
- 2002-06-28 CA CA2451768A patent/CA2451768C/en not_active Expired - Fee Related
- 2002-06-28 EP EP02737668A patent/EP1412336A4/en not_active Withdrawn
- 2002-06-28 EP EP11158209.4A patent/EP2343285B1/en not_active Expired - Lifetime
-
2006
- 2006-11-03 US US11/592,718 patent/US7612036B2/en not_active Expired - Fee Related
-
2008
- 2008-05-23 AU AU2008202303A patent/AU2008202303A1/en not_active Abandoned
- 2008-10-15 JP JP2008266473A patent/JP2009108054A/ja active Pending
-
2009
- 2009-09-11 US US12/558,407 patent/US20100167995A1/en not_active Abandoned
-
2011
- 2011-04-19 AU AU2011201766A patent/AU2011201766B2/en not_active Ceased
- 2011-09-06 US US13/226,229 patent/US20120108499A1/en not_active Abandoned
- 2011-10-04 JP JP2011220320A patent/JP2012067103A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU757059B2 (en) | Quinoline-indole antimicrobial agents, uses and compositions related thereto | |
| JP2010530881A5 (enExample) | ||
| JP2019518046A5 (enExample) | ||
| CN108025191A (zh) | 治疗癌症的方法 | |
| CZ299554B6 (cs) | Sloucenina se strukturou chinolonu, farmaceutickýprostredek ji obsahující a použití | |
| JP2005523922A5 (enExample) | ||
| JP2020040964A (ja) | オキサチアジン様化合物を作製する方法 | |
| HU229935B1 (en) | Dual action antibiotics | |
| CA2422375A1 (en) | 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents | |
| CA2361364A1 (en) | Dalda analogs and their use | |
| JP2007516205A5 (enExample) | ||
| JP2012515195A5 (enExample) | ||
| JP2005504734A5 (enExample) | ||
| CA2539349A1 (en) | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones | |
| WO2022187329A1 (en) | Fabi inhibitors for gram-negative pathogens | |
| JP2001525394A5 (enExample) | ||
| JP2003523394A (ja) | 第一遷移系列元素に対してキレート化親和性および選択性のある化合物とその使用 | |
| CA2451768A1 (en) | Peptoid compounds | |
| RU2004116473A (ru) | Производные пиридина в качестве блокаторов подтипа nmda- рецепторов | |
| CA2510468A1 (en) | Novel 2,4-diamino-1,3,5-triazine derivative | |
| WO2007097450A1 (ja) | 抗マラリア活性化合物、及びそれを有効成分とする抗マラリア薬 | |
| JP2008521934A5 (enExample) | ||
| RU2007125130A (ru) | Применение атазанавира для улучшения фармакокинетики лекарственных средств, метаболизируемых ugt1a1 | |
| JPWO2020246503A1 (ja) | 狂犬病治療のための環状アミド化合物およびその方法 | |
| KR20090009795A (ko) | 벤조퀴놀리진-2-카르복실산의 프로드러그 |